MARC1 Recombinant Protein (OPCD05362) from Aviva Systems Biology

Supplier Page

Supplier Page from
Aviva Systems Biology for
MARC1 Recombinant Protein (OPCD05362)

Request Info

Description

As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively